Patent intelligence · US
US 6514962
Stabilized preparations of &bgr;-lactam antibiotic
Stabilized preparations of &bgr;-lactam antibiotic
Patent details — US 6514962
- Jurisdiction
- US
- Status
- expired
- Grant date
- Feb 4, 2003
- Expiration
- Jan 30, 2023
- Claims
- 15
- CPC classes
- A61K, A61K31/43, A61K31/545, A61K47/02
Quick answer
US 6514962 (Stabilized preparations of &bgr;-lactam antibiotic) is held by Takeda Schering-Plough Animal Health K.K.. Status: expired. Granted Feb 4, 2003. Expires Jan 30, 2023 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Grant date
- Expiration
- Claims
- 15
- CPC classes
- A61K, A61K31/43, A61K31/545, A61K47/02, A61K47/14, A61K47/44
More from Takeda Schering-Plough Animal Health K.K.
Related pharmaceutical patents in our USPTO index.
-
US 12428403
N-(heterocyclyl and heterocyclylalkyl)-3-benzylpyridin-2-amine derivatives as SSTR4 agonists
granted -
US 12421188
Heterocyclic compound and use thereof
granted -
US 12419890
Administration of sumo-activating enzyme inhibitor and checkpoint inhibitors
granted -
US 12415866
Monoclonal antibody inhibitor of Factor XIIa
granted -
US 12415782
Heterocyclic compound and use thereof
granted -
US 12409210
CNS delivery of therapeutic agents
granted -
US 12404237
Method of treating excessive sleepiness and/or cataplexy using n-{2-(([1,1′-biphenyl]-3-yl)methyl)pyrrolidin-3-yl}sulfonamide derivatives
granted -
US 12403154
Administration of sting agonist and checkpoint inhibitors
granted
Frequently asked questions
What is US patent 6514962?
US 6514962 (Stabilized preparations of &bgr;-lactam antibiotic) is held by Takeda Schering-Plough Animal Health K.K.. Status: expired. Granted Feb 4, 2003. Expires Jan 30, 2023 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 6514962?
Takeda Schering-Plough Animal Health K.K. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 1,436 pharmaceutical patents for this assignee.
When does US 6514962 expire?
Our index shows an expiration date of Jan 30, 2023 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.